x
|
Annual
Report pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934 for the fiscal year ended December 31, 2007
|
¨
|
Transition
Report pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934 for the transition period from
to
|
Delaware
|
|
52-2286452
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(IRS
Employer
Identification
No.)
|
30
Two Bridges Road, Suite 270
Fairfield,
NJ
|
|
07004
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
Page
|
PART II
|
|
|
|
Item
8A(T). Controls and Procedures
|
2
|
|
|
PART IV
|
|
|
|
Item
13. Exhibits, Financial Statement Schedules
|
3
|
Signatures
|
4
|
Exhibit No.
|
Description
|
||
3.1
|
Certificate
of Incorporation of the Registrant (incorporated by reference to
Exhibit
3.1 of the Registrant’s Registration Statement on Form SB-2 filed on
October 2, 2002, SEC File No. 333-100259).
|
||
3.2
|
Bylaws
of the Registrant (incorporated by reference to Exhibit 3.2 of the
Registrant’s Registration Statement on Form SB-2 filed on October 2, 2002,
SEC File No. 333-100259).
|
||
10.1
|
Services
Agreement between the Registrant and Fountainhead Capital Management
Limited (previously filed).
|
||
31.1
|
Certification
of Principal Executive Officer filed pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.**
|
||
31.2
|
Certification
of Principal Financial Officer filed pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.**
|
||
32.1
|
Certification
of Principal Executive Officer furnished pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
(previously filed).**
|
||
32.2
|
Certification
of Principal Financial Officer furnished pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
(previously filed).**
|
ARNO
THERAPEUTICS, INC.
|
||
By:
|
/s/
Brian Lenz
|
|
Brian
Lenz
|
||
Chief
Financial Officer
|
Signature
|
Title
|
Date
|
||
/s/
Roger G. Berlin
|
Chief Executive Officer and Director (Principal |
September
11, 2008
|
||
Roger
G. Berlin, M.D.
|
Executive
Officer)
|
|
||
/s/
Brian Lenz
|
Chief Financial Officer (Principal Accounting |
September
11, 2008
|
||
Brian
Lenz
|
and
Financial Officer)
|
|
||
/s/
Arie
S. Belldegrun, M.D.
|
Chairman
of the Board
|
September
12, 2008
|
||
Arie
S. Belldegrun, M.D.
|
|
|
||
/s/
Robert I. Falk
|
Director
|
September
11, 2008
|
||
Robert
I. Falk
|
||||
/s/
Peter M. Kash
|
Director
|
September
11, 2008
|
||
Peter
M. Kash
|
||||
/s/
Joshua A. Kazam
|
Director
|
September
11, 2008
|
||
Joshua
A. Kazam
|
||||
/s/
David M. Tanen
|
Director
|
September
11, 2008
|
||
David
M. Tanen
|
Exhibit
No.
|
Description
|
|
31.1
|
Certification
of Principal Executive Officer filed pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31.2
|
Certification
of Principal Financial Officer filed pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
32.1
|
|
Certification
of Principal Executive Officer furnished pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
(previously filed).
|
32.2
|
Certification
of Principal Financial Officer furnished pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002
(previously filed).
|